Concepedia

Srinivas K. Tantravahi

SK

Statistics

Publications

26

Citations

1.6K

H-Index

16

Active since

2012

Affiliations

University of Utah(Current)

Huntsman Cancer Institute

ARUP Laboratories (United States)

Cleveland Clinic

Dana-Farber Cancer Institute

Srinivas K. Tantravahi is an author at University of Utah specializing in medicine, oncology, and molecular oncology.

ORCID

Publications per year

2012–2024

26

Publications

26

BCR-ABL1 Compound Mutations Combining Key Kinase Domain Positions Confer Clinical Resistance to Ponatinib in Ph Chromosome-Positive Leukemia

Matthew S. Zabriskie, Christopher A. Eide, Srinivas K. Tantravahi et al. · Cancer Cell · 2014 · 366 citations · Full text

, , +7

Impact of Bone and Liver Metastases on Patients with Renal Cell Carcinoma Treated with Targeted Therapy

Rana R. McKay, Nils Kroeger, Wanling Xie et al. · European Urology · 2013 · 253 citations · Full text

, , +16

Age-related mutations and chronic myelomonocytic leukemia

Clinton C. Mason, Jamshid S. Khorashad, Srinivas K. Tantravahi et al. · Leukemia · 2015 · 141 citations · Full text

, , +14

Combined STAT3 and BCR-ABL1 inhibition induces synthetic lethality in therapy-resistant chronic myeloid leukemia

Anna M. Eiring, Brent D. G. Page, Ira L. Kraft et al. · Leukemia · 2014 · 133 citations · Full text

, , +12

Chronic Myeloid Leukemia, Version 2.2024, NCCN Clinical Practice Guidelines in Oncology

Neil P. Shah, Ravi Bhatia, Jessica K. Altman et al. · Journal of the National Comprehensive Cancer Network · 2024 · 118 citations · Full text

, , +15

1–5 of 26